Fintel on MSN10h
Chardan Capital Initiates Coverage of Unity Biotechnology (UBX) with Buy Recommendation
Fintel reports that on January 10, 2025, Chardan Capital initiated coverage of Unity Biotechnology (NasdaqGS:UBX) with a Buy ...
Ibj.com12h
Q&A with Kristin Sherman: Life sciences veteran is fighting for women’s health
Kristin Sherman leads startup Kovina Therapeutics, which is still in the early stages of developing ways to stop human ...
Hosted on MSN1d
Morgan Stanley Upgrades Vir Biotechnology (VIR)
Fintel reports that on January 9, 2025, Morgan Stanley upgraded their outlook for Vir Biotechnology (NasdaqGS:VIR) from Equal ...
BioLizard Welcomes Arjan van Manen as Commercial Director and Announces Presence at JPM Week in San Francisco
Arjan van Manen joins BioLizard as Commercial Director, bringing over 20 years of commercial leadership experience in life sciencesMeet ...
ncbiotech.org2d
Doron Therapeutics raises $11M to advance osteoarthritis biologic into Phase 3 trials
With an aggregate of $11 million raised in an initial Series A funding round, Doron Therapeutics is advancing its lead ...
stocknews2d
3 Biotech Stocks Innovating the Future of Medicine
The biotech industry is booming thanks to the rising demand for personalized medicine, investment in innovations, and ongoing ...
Top 5 Commercial Biotech Buyout Candidates: Mirum Pharmaceuticals (No. 3)
Biotech M&A is heating up, and Mirum Pharmaceuticals stands out. Discover why analysts predict a 50% upside and long-term ...
STAT2d
East Asians under-represented in biopharma leadership
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
TMCnet2d
MPM BioImpact Appoints Brian Shuster, Experienced in Healthcare Corporate Development, as Entrepreneur Partner
MPM BioImpact, a biotechnology investment firm creating and investing in innovative companies seeking to deliver transformative therapies to patients, today announced that Brian Shuster will join the ...
WGBH3d
Women in Biotech: Why women in leadership make a difference
Massachusetts is a hub for biotech: According to the latest MassBio industry snapshot, biopharma accounted for more than 15% of job growth in the entire state in 2023. This month, we’re hearing from ...
Top 5 Commercial Biotech Buyout Candidates: Legend Biotech (No. 4)
Legend Biotech is a commercial-stage biotech company specializing in innovative cell therapies. Click here to find out why I ...
Organovo Announces Appointment of Norman Staskey as Chief Financial Officer
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel ...